Mark P. McLaughlin

1.3k total citations
25 papers, 1.0k citations indexed

About

Mark P. McLaughlin is a scholar working on Surgery, Oncology and Cancer Research. According to data from OpenAlex, Mark P. McLaughlin has authored 25 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 8 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Mark P. McLaughlin's work include Breast Cancer Treatment Studies (6 papers), Head and Neck Cancer Studies (5 papers) and Glioma Diagnosis and Treatment (2 papers). Mark P. McLaughlin is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Head and Neck Cancer Studies (5 papers) and Glioma Diagnosis and Treatment (2 papers). Mark P. McLaughlin collaborates with scholars based in United States, Canada and Switzerland. Mark P. McLaughlin's co-authors include Rodney R. Million, James T. Parsons, Scott P. Stringer, William M. Mendenhall, Nicholas J. Cassisi, Sarah H. Cheeseman, Maureen Myers, J L Sullivan, Stephen A. Spector and Thomas C. Greenough and has published in prestigious journals such as Journal of the American College of Cardiology, Cancer Research and Radiology.

In The Last Decade

Mark P. McLaughlin

23 papers receiving 1.0k citations

Peers

Countries citing papers authored by Mark P. McLaughlin

Since Specialization

Citations

This map shows the geographic impact of Mark P. McLaughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark P. McLaughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark P. McLaughlin more than expected).

Fields of papers citing papers by Mark P. McLaughlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark P. McLaughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark P. McLaughlin. The network helps show where Mark P. McLaughlin may publish in the future.

Co-authorship network of co-authors of Mark P. McLaughlin

This figure shows the co-authorship network connecting the top 25 collaborators of Mark P. McLaughlin. A scholar is included among the top collaborators of Mark P. McLaughlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark P. McLaughlin. Mark P. McLaughlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	1128P Preliminary results of first-in-human study of 225-Actinium MTI-201 (225Ac-MTI-201) in metastatic uveal melanoma 2024 ·Annals of Oncology ·Nikhil I. Khushalani, Ghassan El‐Haddad, Kenneth L. Gage, Mikalai M. Budzevich, Michael J. Schell, Eduardo G. Moros, (unknown), William R. Gibbons, (unknown), (unknown), Leticia Tetteh, Zeynep Eroglu, Lilit Karapetyan, Andrew S. Brohl, Joseph Markowitz, (unknown), (unknown), Lori Hazlehurst, Mark P. McLaughlin, David L. Morse	1
2	Factors Associated With Chest Wall Toxicity After Accelerated Partial Breast Irradiation Using High-Dose-Rate Brachytherapy 2012 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Frank A. Vicini, (unknown), Thomas J. Whitaker, (unknown), Maureen Lyden, (unknown), (unknown), Mark P. McLaughlin	4
3	Three-year clinical outcome using the Contura multilumen balloon breast brachytherapy catheter to deliver accelerated partial breast irradiation (APBI): Improving radiation standards for the optimal application of APBI 2011 ·Brachytherapy ·(unknown), (unknown), (unknown), (unknown), Mark P. McLaughlin, (unknown)	11
4	Ductal Carcinoma in Situ of the Breast Treated with Accelerated Partial Breast Irradiation Using Balloon-Based Brachytherapy 2010 ·Annals of Surgical Oncology ·(unknown), Frank A. Vicini, (unknown), (unknown), Mark P. McLaughlin, (unknown), Maureen Lyden	19
5	A dosimetric comparison of the Contura multilumen balloon breast brachytherapy catheter vs. the single-lumen MammoSite balloon device in patients treated with accelerated partial breast irradiation at a single institution 2010 ·Brachytherapy ·(unknown), Mark P. McLaughlin, (unknown), (unknown), Lorie L. Hughes, (unknown), Maureen Lyden	14
6	Initial radiation experience evaluating early tolerance and toxicities in patients undergoing accelerated partial breast irradiation using the Contura Multi-Lumen Balloon breast brachytherapy catheter 2009 ·Brachytherapy ·(unknown), Mark P. McLaughlin, (unknown), (unknown), (unknown), (unknown)	41
7	Initial radiation experience evaluating early tolerance and toxicities in patients undergoing accelerated partial breast irradiation using the Contura™ multi-lumen balloon (MLB) breast brachytherapy catheter. 2009 ·Cancer Research ·(unknown), Mark P. McLaughlin, (unknown), (unknown), (unknown), Lorie L. Hughes, (unknown)	3
8	A historical prospective cohort study of carotid artery stenosis after radiotherapy for head and neck malignancies 2005 ·International Journal of Radiation OncologyBiologyPhysics ·Paul D. Brown, Robert L. Foote, Mark P. McLaughlin, Michele Y. Halyard, Karla V. Ballman, Alex Collie, Robert C. Miller, Kelly D. Flemming, John W. Hallett	94
9	Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarctionThe controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial 2004 ·Journal of the American College of Cardiology ·Mark P. McLaughlin, Gregg W. Stone, Eve Aymong, Glenn Gardner, Roxana Mehran, Alexandra Lansky, Cindy L. Grines, James E. Tcheng, (unknown), (unknown)	25
10	Prophylactic Placement of Gastrostomy Feeding Tubes Before Radiotherapy in Patients With Head and Neck Cancer 2001 ·Journal of Clinical Gastroenterology ·James S. Scolapio, (unknown), (unknown), Mark P. McLaughlin, John R. Salassa	65
11	Outcome after radiotherapy of primary spinal cord glial tumors 1998 ·Radiation Oncology Investigations ·Mark P. McLaughlin, John M. Buatti, Robert B. Marcus, Bernard L. Maria, Parker Mickle, Amos Kedar	28
12	Ependymoma: Results, Prognostic Factors and Treatment Recommendations 1998 ·International Journal of Radiation OncologyBiologyPhysics ·Mark P. McLaughlin, Robert B. Marcus, John M. Buatti, (unknown), J. Parker Mickle, Amos Kedar, Bernard L. Maria, Rodney R. Million	127
13	Salvage surgery after radiotherapy failure in T1–T2 squamous cell carcinoma of the glottic larynx 1996 ·Head & Neck ·Mark P. McLaughlin, James T. Parsons, Douglas A. Fein, Scott P. Stringer, Nicholas J. Cassisi, William M. Mendenhall, Rodney R. Million	80
14	Retropharyngeal adenopathy as a predictor of outcome in squamous cell carcinoma of the head and neck 1995 ·Head & Neck ·Mark P. McLaughlin, William M. Mendenhall, Anthony Mancuso, James T. Parsons, Patricia J. McCarty, Nicholas J. Cassisi, Scott P. Stringer, Roger P. Tart, Suresh K. Mukherji, Rodney R. Million	104
15	High-Dose Nevirapine: Safety, Pharmacokinetics, And Antiviral Effect In Patients With Human Immunodeficiency Virus Infection 1995 ·The Journal of Infectious Diseases ·Diane V. Havlir, Sarah H. Cheeseman, Mark P. McLaughlin, Robert L. Murphy, Alejo Erice, Stephen A. Spector, Thomas C. Greenough, J L Sullivan, D. B. Hall, Maureen Myers, (unknown), (unknown)	256
16	Quality of life, appetite, and weight change in patients receiving dose-intensive chemotherapy. 1994 ·PubMed ·David Osoba, Nevin Murray, Karen Gelmon, (unknown), Margaret A. Knowling, (unknown), Mark P. McLaughlin, (unknown), (unknown), (unknown)	35
17	Detection of two forms of GP330. Their role in Heymann nephritis. 1993 ·PubMed ·David R. Bachinsky, Gang Zheng, John L. Niles, Mark P. McLaughlin, Mauro Abbate, Giuseppe A. Andres, Dennis Brown, Robert T. McCluskey	50
18	Adjunctive Radiation Therapy for Rectal Carcinoma 1992 ·American Journal of Clinical Oncology ·Robert J. Myerson, Thomas Zusag, Ira J. Kodner, Bruce J. Walz, (unknown), Mark P. McLaughlin, Robert D. Fry, James W. Fleshman, Mary Ann Lockett	14
19	Outpatient metrizamide myelography: prospective evaluation of safety and cost effectiveness. 1986 ·Radiology ·(unknown), R. A. Baker, Francis J. Scholz, Mark P. McLaughlin	7
20	Interactions among binding sites on acetylcholine receptors in membrane and in detergent solution. 1978 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Arthur Karlin, (unknown), (unknown), Susan L. Hamilton, D Wise, Mark P. McLaughlin	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact